Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease
Khendek, Leticia, et al., Hepatology Communications 9.1 (2025): e0594.
Categories: Publications
Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence
Wang, Xiao-Xiao, et al., Diagnostics 14.24 (2024): 2889.
Enhancing Histology Detection in MASH Cirrhosis for Artificial Intelligence Pathology Platform by Expert Pathologist Training
Goodman, Zachary, et al. Liver International Communications, 2024
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH
Abdurrachim, Desiree, et al. Journal of Hepatology (2024).
Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology
Naoumov, Nikolai V., et al. Liver international (2024).
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis
Tong, Xiaofei, et al. Hepatology International (2024): 1-15.
Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment
Kendall, Timothy J., Chng, Elaine, et al. Liver International (2024).
Second harmonic generation digital pathology with artificial intelligence: breakthroughs in studying fibrosis dynamics and treatment response
Nikolai V Naoumov & Elaine Chng. Future Medicine AI (2024).
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory study
Yuan, Hai‐Yang, et al. Liver International (2024).
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
Chen, S., Zhou, J., Wu, X. et al. Hepatol Int (2024). https://doi.org/10.1007/s12072-024-10643-z